Expected earnings - Hypera S.A. ADR
Source: US Earnings Reports
Hypera S.A. ADR (HYPMY) is expected to report for Q2 2025
Hypera Pharma - ADR
NASDAQ: HYPMY
HYPMY Trading
-0.48% G/L:
$4.15 Last:
3,850 Volume:
$4.21 Open:
